Reference 1. Kim J. Arch Aesthetic Plast Surg2014;20(2):97-103. 2. Wu Y, et al. J CosmetDermatol 2020:19(7):1627-1635. 3. Belmontesi M, De Angelis F,Di Gregorio C, et al. J Drugs Dermatol. 2018;17(1):83-88. 4. Reuther T, Bayrhammer J, Kerscher M. ArchDermatol Res. 2010;302:37-45. 5. Streker M, Reuther T, Krueger N, et al. J DrugsDermatol. 2013;12:990-994. 6. Galderma. Data on file (MA-39929). 7. GlobeNewswire. RESTYLANE Vital approved inEurope. PR Release 2004 (v1.0). Available at:https://www.globenewswire.com/en/news-release/2004/05/27/311074/1036/en/RESTYLANE-Vital-approved-in-Europe.html(Accessedon18August2023) 8. Dierickx C, et al. Dermatol Surg 2018;44 Suppl1:5104-518. 9. Gubanova E, et al. J Drugs Dermatol2015;14(3):288-298. 10. Kerscher M, et al. Dermatol Surg2008;34(5):720-726. 11. Lee B, et al. Arch Plast Surg2015;42(3):282-287. 12. Ribé A, et al. J Cosmet Laser Ther2011:13(4):154-161. 13. Williams S, et al. J Cosmet Dermatol2009;8(3):216-225. 14. Edsman K, et al. J Dermatol Surg 2012;38(7 Pt2): 1170-1179. 15. Gubanova El, et al. Esteticheskaya Meditsina(Aesthetic Medicine). 2010;1:94-98. 16. Restylane® Skinboosters™ VITAL EU IFU. 17. Restylane® Skinboosters™’ VITAL LIGHT EU IFU. 18. Modern Aesthetics. Allergan launches JuvédermVolite. Available at:https://modernaesthetics.com/news/allergan-launches-juvderm-volite.Accessed November 2022. 19. IBSA Nordic. Profhilo. Available at:https://www.ibsanordic.com/therapeutic-areas/aestheticmedicine/Profhilo.html.Accessed November 2022. 20. Galderma. Data on file (MA-54615). 21. Data on file (MA-39680): Data on file(MA-40221); Data on file (MA-39613).